FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Linghai ZhanWang Records Show CGMP Violations

[ Price : $8.95]

FDA warns Chinas Linghai ZhanWang Biotechnology Co. about CGMP violations in its manufacturing of over-the-counter drugs.

Positive Data on Pfizer/Arvinas Breast Cancer Study

[ Price : $8.95]

Pfizer and Arvinas announce positive topline results from a clinical trial evaluating vepdegestrant monotherapy versus fulvestrant...

FDA Rejects All Mid-Link Technology Data

[ Price : $8.95]

FDA tells Chinas Mid-Link Technology Testing Co. it is rejecting all data from all studies conducted by the company until it provi...

Clinical Researchers Plead Guilty to Fraud

[ Price : $8.95]

Two clinical research facility owners plead guilty in Florida federal court to conspiracy to commit wire fraud in connection with ...

FDA Warns 6 Firms on Unapproved Fat-Dissolving Drugs

[ Price : $8.95]

FDA warns six companies that they are marketing unapproved fat-dissolving drugs.

Sydnexis NDA Accepted for Pediatric Myopia

[ Price : $8.95]

FDA accepts a Sydnexis NDA for SYD-101 (topical low-dose atropine) for treating progression of pediatric myopia.dr

FDA Taps Jim Traficant as Chief of Staff

[ Price : $8.95]

FDA names former business consultant Jim Traficant as chief of staff where he will oversee and lead the agencys major initiatives....

Mineralys Nets Positive Data in Hypertension Drug Studies

[ Price : $8.95]

Mineralys Therapeutics reports positive topline data from its pivotal Launch-HTN Phase 3 and pivotal Advance-HTN Phase 2 trials as...

FDA Clarifies Compounding Policy for GLP-1 Products

[ Price : $8.95]

FDA clarifies its policies for compounders of GLP-1 products for weight-loss and treating diabetes following a court ruling in Tex...

Dexcom Hit With Warning After 2 Inspection

[ Price : $8.95]

Dexcom says it received an FDA Warning Letter following inspections at the companys facilities in San Diego, CA and Mesa, AZ.